GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal shared by more than 50 types of cancer through a routine blood draw for adults with elevated cancer risk, such as those aged 50 or older. When a cancer signal is detected, the Galleri test can predict the cancer signal origin. For important safety information visit Galleri.com/employer
